Lundbeck
From Wikicompany
| H. Lundbeck A/S | |
|---|---|
Contacts | |
| Web: | http://www.lundbeck.com |
| Email: | information@lundbeck.com |
| Phone: | +45-36-30-13-11 |
| Fax: | +45 36 30 19 40 |
| Address: | Ottiliavej 9, DK-2500 Valby, Denmark |
| Geocode: | |
Info | |
| Founding: | 1915 |
| Employees: | |
Relations | |
| Parents: | |
| Subsidiaries: | |
| Affiliates: | |
| Partners: | |
| Customers: | |
| Competitors: | |
Web | |
| Web: | google, yahoo |
| News: | google, yahoo |
| Blogs: | google, technorati |
| Articles: | g-scholar, g-books, worldcat, bookfinder, del.icio.us |
| Financial: | google, yahoo, hoovers, bloomberg |
| Images: | google, yahoo, flickr |
| Audio: | podzinger, odeo, podscope |
| Video: | google, youtube |
H. Lundbeck A/S (also known as Lundbeck) Template:Cse is a Danish pharmaceutical company, engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders.
History
The company was founded by Hans Lundbeck in 1915, and was initially a trading company supplying a variety of goods to the Danish market, including machinery for manufacturing, aluminium foil, artificial sweeteners and photographic equipment.
<imager>http://www.lundbeck.com/INFOSITE/Image_library/Products/LowRes/Cipralex.jpg|200|120|Lundbeck Cipralex antidepressant medication</imager>
Lundbeck entered the pharmaceutical market in 1924, importing medicines and cosmetics from companies based in other European and American countries.
By the late 1930s, Lundbeck had begun to produce its own medicinal products and had established its own research department. Production continued (although limited due to a lack of raw materials) during the Second World War.
After the war, Lundbeck continued to grow, and became a major international pharmaceutical company focusing on the production of drugs used to treat disorders and diseases of the central nervous system.
In 2003, the company's revenue was DKK 9.9 billion.






News
- Lundbeck moves to Phase III with alcoholism drug - Reuters
- Lundbeck starts Phase III trial for stroke drug - Reuters
- Paion's partner Lundbeck initiates Phase III ischemic stroke study - Pharmaceutical Business Review
- Lundbeck begins neurological drug trials - Hays Pharma
- Myriad Genetics' Meldrum Is Best In Biotech - TheStreet.com
- DAILY GLOBE, Worthington Daily Globe - Worthington Daily Globe
- Article by Justin Hill, Ph.D. and Parjette Tawana - Mondaq News Alerts (registration)
- » Clinical Research Associate - Hays Pharma
- Health Care's Golden Children - Motley Fool
- The Best and Worst of Biotech in 2008 - TMCnet
- ... more news
Blogs
- H. Lundbeck - Process Manager (English)
- H. Lundbeck - Medical Safety Advisor
- Lundbeck moves Lu AA39959 into clinical phase II for the treatment ...
- PAION’s Partner Lundbeck Initiates Clinical Phase III Trials With ...
- Lundbeck preps Phase III trials for alcoholism
- Lundbeck Initiates Clinical Phase III Trials With Desmoteplase in ...
- Lundbeck initiates phase III trials of nalmefene
- Lundbeck initiates schizophrenia studies - Hays Pharma
- Lundbeck initiates phase III clinical trials with nalmefene as a ...
- Lundbeck initiates clinical phase III trials with desmoteplase in ...
- ... more blog news
Video
Lundbeck properties
RDF feed| Address | Ottiliavej 9, DK-2500 Valby, Denmark +address lookup |
| Information@lundbeck.com + | |
| Exchange | CSE + |
| Fax | +45 36 30 19 40 + |
| Founding | 1915 + |
| Fullname | H. Lundbeck A/S + |
| Homepage | http://www.lundbeck.com + |
| Phone | +45-36-30-13-11 + |
| Region | Valby +, Denmark +, and Europe + |
| Sector | Pharmacology +, healthcare +, and medicine + |



